Overview

The Cell Culture Market is estimated to value over CAGR of over 11.6% from the forecast period 2022 to 2028.

Increasing awareness about the benefits of culture-based vaccines and rising adoption for single-use technologies are the major factors driving the market growth. Growing demand for monoclonal antibodies and rising investments for cell-based research is augmenting the market. Factors such as increasing attention towards personalized medicine and the development of many biopharmaceutical products such as therapeutic and vaccines are driving the market. 

FutureWise Market Research has instantiated a report that provides an intricate analysis of Cell Culture Market Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Cell Culture Market Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

Cell Culture Market Overview:
The market is classified into by product, application, end-user, and region. Based on type, the cell structure is segmented into sera, media & reagents, vessels and bioreactor accessories. Sera, media & reagents are expected to dominate the growth of the market. 
Reagents such as antibiotics are effective towards contamination and possible toxicity and contamination detection kits are more efficient and faster than other direct culture methods. Serum-free media eliminates the risk of contamination posed by viruses. Owing to these factors, there has been a spike in the demand of sera, media and reagents thus propelling the market.
In terms of application, biopharmaceutical production is expected to hold a vast share of the market. The increasing demand for therapeutic proteins is driving the demand for biopharmaceutical production thus positively influencing the market. Rising incidences of diseases have led to more demand for vaccine production which expands the market. The increasing demand for single-use technologies and growing government approvals towards cell culture-based vaccines are fueling the market. 

In terms of regions, North America is the global leader of the market. Government and private enterprises rising interest in vaccines related to cell culture and higher investments in cell-based research are driving the growth of the market in the region. Strong government support for R&D activities is boosting the presence of the market in the region. In terms of end-users, pharmaceutical and biotechnological companies are the front runners due to their large consumption of cell culture for bioproduction. Expansion of major biopharmaceutical players has also bolstered the market. Asia-Pacific region is predicted to be a lucrative region owing to increasing government support of emerging economies like India and China for biotech research. Large population size and government policies favoring biopharmaceutical manufacturing have lured the prominent players to penetrate into the region.

Major players included in the Cell Culture Market Market:
• Thermo Fisher Scientific Inc.
• Merck Kgaa
• Becton, Dickinson And Company
• Corning Incorporated
• Danaher Corporation
• Eppendorf Ag
• Fujifilm Irvine Scientific, Inc. (Acquired By Fujifilm Corporation)
• Lonza Group Ag
• Sartorius Ag
• Cellgenix Gmbh
• Miltenyi Biotec
• Stemcell Technologies, Inc.
• Himedia Laboratories
• Invivogen
• Infors Ag
• Promocell
• Pan Biotech Gmbh
• Seracare Life Sciences Incorporation
• Caisson Labs
• Solida Biotech Gmbh
(Note: The list of the major players will be updated with the latest market scenario and trends)
Competitive Landscape:
●     Thermo Fisher Scientific in 2019 invested USD 150 million to expand its capacity of lyophilized product development and sterile liquids. Their centers across Italy and the US will have aseptic filling lines alongside isolator technology which will help in strengthening the company's customer base worldwide
●     Merck in 2018 opened its BioReliance biosafety testing lab in Singapore. Their new lab will offer critical testing services which would further augment the market
●     Fujifilm in 2018, acquired IS JAPAN CO., LTD, and Irvine Scientific. The move helped Fujifilm enhance regenerative medicine and reagent business, hence bolstering the company's foothold in the market
 
Cell Culture Market Segmentation :

By Product
• Consumables
  o Sera, Media, and Reagents
    • Media
      o Serum-free Media
      o Classical Media & Salts
      o Stem Cell Culture Media
      o Specialty Media                                            
    • Reagents
      o Growth Factors
      o Supplements
      o Buffers & Chemicals
      o Cell Dissociation Reagents
      o Balanced Salt Solutions
      o Attachment & Matrix Factors
      o Antibiotics/antimycotics
      o Contamination Detection Kits
      o Cryoprotective Reagents
      o Other Cell Culture Reagents
    • Sera
      o Fetal Bovine Sera(Fbs)
      o Adult Bovine Sera (Abs)
      o Other Animal Sera
  o Vessels
    • Roller/roux Bottles
    • Cell Factory Systems/cell Stacks
    • Multiwell Plates
    • Flasks
    • Petri Dishes
  o Bioreactor Accessories
• Equipment
  o Supporting Equipment
    • Filtration Systems
    • Cell Counters
    • Carbon Dioxide Incubators
    • Centrifuges
    • Autoclaves
    • Microscopes
    • Biosafety Cabinets
    • Other Supporting Equipment
  o Bioreactors
    • Conventional Bioreactors
    • Single-use Bioreactors
  o Storage Equipment
    • Refrigerators & Freezers
    • Cryostorage Systems

By Application
• Biopharmaceutical Production
  o Therapeutic Proteins
  o Vaccine Production
• Diagnostics
• Drug Screening & Development
• Stem Cell Research
• Tissue Engineering And Regenerative Medicine
• Other Applications

By End User
• Pharmaceutical & Biotechnology Companies
• Hospitals And Diagnostic Laboratories
• Research & Academic Institutes
• Cell Banks

By Region
●  North America
●  Europe
●  Asia Pacific
●  Latin America
●  Middle East and Africa

FutureWise Key Takeaways:
●     According to our industry experts, single-use bioreactors are expected to witness immense demand owing to the rising adoption of single-use technologies. Single-use technologies offer benefits such as low price and low contamination risk. In addition, the demand for mAbs is also fueling the demand of single-use bioreactors thus propelling the market
●     Europe is expected to be a high growth profit region owing to the growing support of private investors and the government for R&D activity in countries like Germany and France. Expansion of the life science industry in the UK is also positively influencing the market.

Objectives of the Study:
• To provide with an exhaustive analysis on the global cell culture market by product, by application, by end-user and by region
• To cater to comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions (along with countries)—North America, Europe, Asia Pacific, Latin America and the Middle East and Africa
• To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers, and expansions
• Profiling of companies to evaluate their market shares, strategies, financial and core competencies

Flexible Delivery Model:
• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
• The customization services offered are free of charge with purchase of any license of the report.
• You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents

1. Market Introduction
   1.1. Objectives of the Study 
   1.2. Market Definition 
   1.3. Market Scope 
        1.3.1. Years Considered for the Study
        1.3.2. Market Covered
   1.4. Currency 
   1.5. Limitations 
   1.6. Stakeholders 

2. Research Methodology 
   2.1. Research Data 
        2.1.1. Secondary Data
               2.1.1.1. Key Data from Secondary Sources
        2.1.2. Primary Data
               2.1.2.1. Key Data from Primary Sources
   2.2. Market Size Estimation 
   2.3. Market Breakdown and Data Triangulation 
   2.4. Assumptions for the Study  

3. Executive Summary
   3.1. Market Outlook
   3.2. Segment Outlook
   3.3. Competitive Insights

4. Global Cell Culture Market Market Variables, Trends & Scope
   4.1. Market Lineage Outlook
   4.2. Penetration and Growth Prospect Mapping
   4.3. Industry Value Chain Analysis
   4.4. Cost Analysis Breakdown
   4.5. Technology Overview
   4.6. Regulatory Framework
        4.6.1. Reimbursement Framework
        4.6.2. Standards and Compliances

5. Market Overview
   5.1. Market Dynamics
        5.1.1. Market Driver Analysis
               5.1.1.1. Increasing focus of Cell Culture Market Companies on Brand Protection
               5.1.1.2. Untapped Opportunities in Emerging Regions
        5.1.2. Market Restraint Analysis
               5.1.2.1. High Cost Associated with Implementation of Predictive Analysis
        5.1.3. Industry Challenges
               5.1.3.1. Presence of Ambiguous Regulatory Framework

6. Cell Culture Market Market Analysis Tools
   6.1. Industry Analysis - Porter’s
        6.1.1. Supplier Power
        6.1.2. Buyer Power
        6.1.3. Substitution Threat
        6.1.4. Threat from New Entrants
        6.1.5. Competitive Rivalry
   6.2. Pestel Analysis
        6.2.1. Political Landscape
        6.2.2. Environmental Landscape
        6.2.3. Social Landscape
        6.2.4. Technology Landscape
        6.2.5. Legal Landscape
   6.3. Major Deals And Strategic Alliances Analysis
        6.3.1. Joint Ventures
        6.3.2. Mergers and Acquisitions
        6.3.3. Licensing and Partnership
        6.3.4. Technology Collaborations
        6.3.5. Strategic Divestments
   6.4. Market Entry Strategies
   6.5. Case Studies

7. Cell Culture Market Market, By Product Historical Analysis and Forecast 2022-2028 (USD Million)
   7.1. Consumables   
        7.1.1. Sera, Media, and Reagents
               7.1.1.1. Media
                        7.1.1.1.1. Serum-free Media
                        7.1.1.1.2. Classical Media & Salts
                        7.1.1.1.3. Stem Cell Culture Media
                        7.1.1.1.4. Specialty Media                                            
               7.1.1.2. Reagent
                        7.1.1.2.1. Growth Factors
                        7.1.1.2.2. Supplements
                        7.1.1.2.3. Buffers & Chemicals
                        7.1.1.2.4. Cell Dissociation Reagents
                        7.1.1.2.5. Balanced Salt Solutions
                        7.1.1.2.6. Attachment & Matrix Factors
                        7.1.1.2.7. Antibiotics/antimycotics
                        7.1.1.2.8. Contamination Detection Kits
                        7.1.1.2.9. Cryoprotective Reagents
                        7.1.1.2.10. Other Cell Culture Reagents
               7.1.1.3. Sera
                        7.1.1.3.1. Fetal Bovine Sera(Fbs)
                        7.1.1.3.2. Adult Bovine Sera (Abs)
                        7.1.1.3.3. Other Animal Sera
        7.1.2. Vessels
               7.1.2.1. Roller/roux Bottles
               7.1.2.2. Cell Factory Systems/cell Stacks
               7.1.2.3. Multiwell Plates
               7.1.2.4. Flasks
               7.1.2.5. Petri Dishes
        7.1.3. Bioreactor Accessories
   7.2. Equipment
        7.2.1. Supporting Equipment
               7.2.1.1. Filtration Systems
               7.2.1.2. Cell Counters
               7.2.1.3. Carbon Dioxide Incubators
               7.2.1.4. Centrifuges
               7.2.1.5. Autoclaves
               7.2.1.6. Microscopes
               7.2.1.7. Biosafety Cabinets
               7.2.1.8. Other Supporting Equipment
        7.2.2. Bioreactors
               7.2.2.1. Conventional Bioreactors
               7.2.2.2. Single-use Bioreactors
        7.2.3. Storage Equipment
               7.2.3.1. Refrigerators & Freezers
               7.2.3.2. Cryostorage Systems

8. Global Cell Culture Market Market, By Application Historical Analysis and Forecast 2022-2028 (USD Million)  
   8.1. Biopharmaceutical Production
        8.1.1. Therapeutic Proteins
        8.1.2. Vaccine Production
   8.2. Diagnostics
   8.3. Drug Screening & Development
   8.4. Stem Cell Research
   8.5. Tissue Engineering And Regenerative Medicine
   8.6. Other Applications

9. Global Cell Culture Market Market, By End User Historical Analysis and Forecast 2022-2028 (USD Million)  
   9.1. Pharmaceutical & Biotechnology Companies
   9.2. Hospitals And Diagnostic Laboratories
   9.3. Research & Academic Institutes
   9.4. Cell Banks

10. North America Cell Culture Market Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million)
    10.1. Introduction
    10.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
          10.2.1. U.S.A
          10.2.2. Canada
          10.2.3. Mexico
    10.3. Market Size (USD Million) Forecast for North America 2022-2028

11. Latin America Cell Culture Market Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million)
    11.1. Introduction
    11.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
          11.2.1. Brazil
          11.2.2. Venezuela
          11.2.3. Argentina
          11.2.4. Rest of Latin America
    11.3. Market Size (USD Million) Forecast for Latin America 2022-2028

12. Europe Cell Culture Market Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million)
    12.1. Introduction
    12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
          12.2.1. Germany
          12.2.2. U.K         
          12.2.3. France
          12.2.4. Italy
          12.2.5. Spain
          12.2.6. Russia
          12.2.7. Poland
          12.2.8. Rest of Europe
    12.3. Market Size (USD Million) Forecast for Europe 2022-2028

13. Asia Pacific Cell Culture Market Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million)
    13.1. Introduction
    13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
          13.2.1. Japan
          13.2.2. China
          13.2.3. India
          13.2.4. Australia and New Zealand
          13.2.5. ASEAN
          13.2.6. Rest of Asia Pacific
    13.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028  

14. Middle East and Africa Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million)
    14.1. Introduction
    14.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
          14.2.1. GCC
          14.2.2. Israel
          14.2.3. South Africa
          14.2.4. Rest of MEA
    14.3. Market Size (USD Million) Forecast for MEA 2022-2028

15. Market Share Analysis and Competitive Landscape   
    15.1. Global Landscape - Key Players, Revenue and Presence
    15.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
    15.3. Global Emerging Companies
    15.4. North America - Market Share Analysis and Key Regional Players
    15.5. Europe - Market Share Analysis and Key Regional Players
    15.6. Asia Pacific - Market Share Analysis and Key Regional Players
    15.7. Global Key Player - Growth Matrix

16. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    16.1. Thermo Fisher Scientific Inc.
          16.1.1. Company Overview
          16.1.2. Product Portfolio
          16.1.3. SWOT Analysis
          16.1.4. Financial Overview
          16.1.5. Strategic Overview
    16.2. Merck Kgaa
          16.2.1. Company Overview
          16.2.2. Product Portfolio
          16.2.3. SWOT Analysis
          16.2.4. Financial Overview
          16.2.5. Strategic Overview 
    16.3. Becton, Dickinson And Company
          16.3.1. Company Overview
          16.3.2. Product Portfolio
          16.3.3. SWOT Analysis
          16.3.4. Financial Overview
          16.3.5. Strategic Overview
    16.4. Corning Incorporated
          16.4.1. Company Overview
          16.4.2. Product Portfolio
          16.4.3. SWOT Analysis
          16.4.4. Financial Overview
          16.4.5. Strategic Overview
    16.5. Danaher Corporation
          16.5.1. Company Overview
          16.5.2. Product Portfolio
          16.5.3. SWOT Analysis
          16.5.4. Financial Overview
          16.5.5. Strategic Overview          
    16.6. Eppendorf Ag
          16.6.1. Company Overview
          16.6.2. Product Portfolio
          16.6.3. SWOT Analysis
          16.6.4. Financial Overview
          16.6.5. Strategic Overview      
    16.7. Fujifilm Irvine Scientific, Inc. (Acquired By Fujifilm Corporation)
          16.7.1. Company Overview
          16.7.2. Product Portfolio
          16.7.3. SWOT Analysis
          16.7.4. Financial Overview
          16.7.5. Strategic Overview
    16.8. Lonza Group Ag
          16.8.1. Company Overview
          16.8.2. Product Portfolio
          16.8.3. SWOT Analysis
          16.8.4. Financial Overview
          16.8.5. Strategic Overview 
    16.9. Sartorius Ag
          16.9.1. Company Overview
          16.9.2. Product Portfolio
          16.9.3. SWOT Analysis
          16.9.4. Financial Overview
          16.9.5. Strategic Overview 
    16.10. Cellgenix Gmbh
          16.10.1. Company Overview
          16.10.2. Product Portfolio
          16.10.3. SWOT Analysis
          16.10.4. Financial Overview
          16.10.5. Strategic Overview 
    16.11. Miltenyi Biotec
          16.11.1. Company Overview
          16.11.2. Product Portfolio
          16.11.3. SWOT Analysis
          16.11.4. Financial Overview
          16.11.5. Strategic Overview      
    16.12. Stemcell Technologies, Inc.
          16.12.1. Company Overview
          16.12.2. Product Portfolio
          16.12.3. SWOT Analysis
          16.12.4. Financial Overview
          16.12.5. Strategic Overview 
    16.13. Himedia Laboratories
          16.13.1. Company Overview
          16.13.2. Product Portfolio
          16.13.3. SWOT Analysis
          16.13.4. Financial Overview
          16.13.5. Strategic Overview
    16.14. Invivogen
          16.14.1. Company Overview
          16.14.2. Product Portfolio
          16.14.3. SWOT Analysis
          16.14.4. Financial Overview
          16.14.5. Strategic Overview
    16.15. Infors Ag
          16.15.1. Company Overview
          16.15.2. Product Portfolio
          16.15.3. SWOT Analysis
          16.15.4. Financial Overview
          16.15.5. Strategic Overview          
    16.16. Promocell
          16.16.1. Company Overview
          16.16.2. Product Portfolio
          16.16.3. SWOT Analysis
          16.16.4. Financial Overview
          16.16.5. Strategic Overview      
    16.17. Pan Biotech Gmbh
          16.17.1. Company Overview
          16.17.2. Product Portfolio
          16.17.3. SWOT Analysis
          16.17.4. Financial Overview
          16.17.5. Strategic Overview
    16.18. Seracare Life Sciences Incorporation
          16.18.1. Company Overview
          16.18.2. Product Portfolio
          16.18.3. SWOT Analysis
          16.18.4. Financial Overview
          16.18.5. Strategic Overview 
    16.19. Caisson Labs
          16.19.1. Company Overview
          16.19.2. Product Portfolio
          16.19.3. SWOT Analysis
          16.19.4. Financial Overview
          16.19.5. Strategic Overview 
    16.20. Solida Biotech Gmbh
          16.20.1. Company Overview
          16.20.2. Product Portfolio
          16.20.3. SWOT Analysis
          16.20.4. Financial Overview
          16.20.5. Strategic Overview 

17. Pre and Post COVID-19 Impact
    17.1. Positive influence on the healthcare industry
    17.2. The financial disruption of the manufacturing sector
    17.3. Impact of COVID-19 on emerging companies
    17.4. Significant mandates in the healthcare regulations initiated by administrations
    17.5. The overall economic slowdown of the developing and developed nations

18. FutureWise SME Key Takeaway Points for Client

Tables

Figures